Delivery Order SPE2DB20D2104-SPE2DB24FV60L

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of LUMIGAN 0.01% eye drops in 5ml quantities. The $2,471.04 fixed-price contract was awarded by the Defense Logistics Agency (DLA) on June 5, 2024, with a completion date of June 6, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply LUMIGAN 0.01% eye drops. The $1,574.72 firm fixed-price delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of LUMIGAN 0.01% eye drops. The $1,307.16 firm-fixed-price contract has an ultimate completion date of April 11, 2023. This contract is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a wide range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of LUMIGAN 0.01% eye drops in 7.5 ml vials. The $1,469.64 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 9, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide...
This federal contract award is for the delivery of LUMIGAN 0.01% eye drops, 2.5 ml, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $2,210.74. The contract is a delivery order, with a firm fixed price, and has an ultimate completion date of August 15, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,350.48 firm fixed-price delivery order is for Lumigan 0.01% eye drops, a branded ophthalmic medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a primary vehicle for...
This federal contract award, valued at $1,353.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of LUMIGAN 0.01% eye drops in 5ml vials. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,821.22, is for the delivery of LUMIGAN 0.01% eye drops in 5ml bottles. The award is a Firm Fixed Price Delivery Order with a completion date of June 7, 2024. This contract is not designated as a set-aside. Amerisourcebergen is the prime contractor, and the contract is part of a larger Indefinite...
This federal contract award is for the delivery of LUMIGAN 0.01% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,457.37, was made to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 21, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,088.89 firm fixed-price delivery order is for the supply of Lumigan 0.01% eye drops, a specialty ophthalmic medication. The contract, which has a completion date of June 16, 2023, is not designated under any set-aside program. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FV60L
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LUMIGAN 0.01% eye drops in 5ml quantities. The $4,376.13 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 2/27/25, 11:06 AM